finance.yahoo.com
The Week Ahead In Biotech: A Quiet One Ahead Of Labor Day Weekend
The biotech space saw a few FDA decisions and clinical readouts over the last week. The FDA handed down two verdicts, backing Nabriva Therapeutics PLC – ADR (NASDAQ: NBRV )'s novel antibiotic while turning ...